EU patent creeps closer

Johnson, Alan; Gibson, Jane
July 2006
ICIS Chemical Business;7/17/2006, Vol. 1 Issue 28, p16
Trade Publication
The article analyzes a variety of issues related to the Community Patent in the European Union. The cost of obtaining patent protection in Europe is a major concern for all industry. The European Patent Office is the centralized granting authority in Europe. It is hoped that the Community Patent will be effective automatically throughout the European Union. The implications of the Community Patent to various industries are mentioned.


Related Articles

  • European Patent Filings Up, but Pharma Stays Flat. Peters, Rita // BioPharm International;Apr2013, Vol. 26 Issue 4, p9 

    The article reports on the 5.2% incease in patent filings at the European Patent Office (EPO) in 2012 as compared to 2011 while the pharmaceutical-based patents has remained flat

  • EU seeks Euro patent harmonization.  // Medical Device Daily;3/15/2011, Vol. 15 Issue 50, p7 

    The article reports on an announcement by the European Patent Office that it is working on a unitary patent system for European Union (EU) countries.

  • Rumblings from the fringe. Abbott, Alison // Nature;2/23/2006, Vol. 439 Issue 7079, p910 

    The article focuses on the plan of the members of the European Union's European Patent Office (EPO) in Munich to put up EPO headquarters in Hague, the Netherlands and Berlin, Germany. In March 2006, members of the EPO's founding convention will meet in Munich to discuss whether some of the...

  • Patent oppositions and opposition outcomes: evidence from domestic appliance companies. Sterlacchini, Alessandro // European Journal of Law & Economics;Feb2016, Vol. 41 Issue 1, p183 

    This paper examines the extent and determinants of patent oppositions and opposition outcomes between the main competitors in the European market of large domestic appliances. By considering the patents issued by the EPO from 2000 to 2005, it is shown that the probability of a patent to be...

  • Supplementary protection certificates for combination products: new combinatorics? Gassner, Ulrich M. // Journal of Intellectual Property Law & Practice;Jan2012, Vol. 7 Issue 1, p52 

    Legal context According to the WHO, the development of fixed-dose combinations of drugs is becoming increasingly important from a public health perspective. Furthermore, such combination products play a more and more critical role in lifecycle strategies of originator pharmaceutical companies....

  • Significant Advances toward a Unitary European Patent. Heine, Christian K. // Landslide;Mar/Apr2012, Vol. 4 Issue 4, p25 

    The article discusses the possibility of a unitary European Patent (EP) through the efforts of the European Union (EU) and the European Patent Convention (EPC). It notes the conditions of the granting of EPs such as the European Patent Office (EPO) should be responsible for granting the EP to...

  • The impact of European embryonic stem cell patent decisions on research strategies. Mahalatchimy, AurĂ©lie; Rial-Sebbag, Emmanuelle; Duguet, Anne-Marie; Taboulet, Florence; Cambon-Thomsen, Anne // Nature Biotechnology;Jan2015, Vol. 33 Issue 1, p41 

    The article focuses on impacts due to human embryonic stem cell (hESC) patent restrictions by the European Patent Office (EPO) and the Court of Justice of the European Union (CJEU) on research and development strategies. It mentions the positive aspects of the same such as shifting of...

  • The Transitional Period of the Agreement on a Unified Patent Court. Tilmann, Winfried // Journal of Intellectual Property Law & Practice;Jul2014, Vol. 9 Issue 7, p575 

    The Transitional Period of the Agreement on a Unified Patent Court provides for the options to still use the national courts or to opt out of the competence of the UPC. Both options raise a number of questions which are discussed in this Article and which reveal that the two options are...

  • Three CJEU decisions that answer some questions but pose many more. Snodin, Mike // Journal of Intellectual Property Law & Practice;Jul2014, Vol. 9 Issue 7, p599 

    On 12 December 2013, the Court of Justice of the European Union (CJEU) issued judgements in three cases that raised fundamental questions regarding the operation of the system of Supplementary Protection Certificates (SPCs) in Europe.The judgements given by the CJEU provide patent offices and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics